Clopidogrel - paediatric investigation plan

clopidogrel

Key facts

• Invented name:
  • Iscover
  • Iscover
• Active Substance:
  clopidogrel
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/123/2008
• PIP number:
  Clopidogrel
• Pharmaceutical form(s):
  • Oral formulation
  • Film-coated tablet
• Condition(s) / indication(s):
  Thromboembolic events
• Route(s) of administration:
  Oral use
• Contact for public enquiries:

  Bristol-Myers Squibb Pharma EEIG

  E-mail: [e-mail]; Country: France; Phone: [phone]; Fax: [phone]

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  05/12/2008

Decision

P/123/2008: European Medicines Agency decision of 5 December 2008 on the application for modification of an agreed Paediatric Investigation Plan for clopidogrel (Iscover) EMEA-000050-PIP01-07-M01 in accordance with Regul...

AdoptedReference Number: EMEA/626714/2008